2021
Vanda D., Canale V., Chaumont-Dubiel S., Kurczab R., Sałata G., Koczurkiewicz-Adamczyk P., Krawczyk M., Pietruś W., Blicharz K., Pękala E., Bojarski AJ., Popik P., Marin P., Soural M., Zajdel P. Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States. J. Med. Chem. 2021, 64, 1180-1196
Ručilová V., Świerczek A., Vanda D., Funk P., Lemrová B., Gawalska A., Bucki A., Nowak B., Zadrożna M., Pociecha K., Soural M., Wyska E., Pawłowski M., Chłoń-Rzepa G., Zajdel P. New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases. Eur. J. Med. Chem. 2021, 209, 112854
2020
Canale V., Grychowska K., Kurczab R., Ryng M., Keeri Abdul R., Satała G., Olejarz-Maciej A., Koczurkiewicz P., Drop M., Blicharz K., Piska K., Pękala E., Janiszewska P., Krawczyk M., Walczak M., Chaumont-Dubel S., Bojarski A., Marin P., Popik P., Zajdel P. A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties. Eur. J. Med. Chem., 2020, 208, 112765
Berthoux C., Hamieh Al M., Rogliardo A., Doucet Emilie L., Coudert C., Ango F., Grychowska K., Chaumont-Dubel S., Zajdel P., Maldonado R., Bockaert J., Marin P, Becamel C. Early 5-HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse. EMBO Molecular Medicine 2020, 12, e10605
Martin Pierre-Y., Doly S., Hamieh Al M., Chapuy E., Canale V., Drop M., Chaumont-Dubel S., Bantreil X., Lamaty F., Bojarski A., Zajdel P., Eschalier A., Marin P., Courteix C. mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment. Progr. Neurobiol. 2020, 193, 101846
Canale V., Frisi V., Bantreil X., Lamaty F., Zajdel P. Sustainable Synthesis of a Potent and Selective 5-HT7 Receptor Antagonist Using a Mechanochemical Approach J. Org. Chem. 2020, 85, 16
Staroń J., Kurczab R., Warszycki D., Satała G., Krawczyk M., Bugno R., Lenda T., Popik P., Hogendorf A S., Hogendorf A., Dubiel K., Matłoka M., Moszczyński – Pętkowski R., Pieczykolan J., Wieczorek M., Zajdel P., Bojarski A J. Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties. Eur. J. Med. Chem, 2020, 185, 111857
Szafrański P., Trybula M.E., Kasza P., Cegła M. Following the oxidation state of organosulfur compounds with NMR : Experimental data versus DFT calculations and database-powered NMR prediction. J. Mol. Struct, 2020, 1202, 127346
2019
Kasza P., Trybula M.E., Baradziej K., Kepczynski M., Szafrański P.W., Cegła M.T. Fluorescent triazolyl spirooxazolidines: Synthesis and NMR stereochemical studies. J. Mol. Struc., 2019, 1183, 157-167
2017
Smaga I., Zaniewska M., Gawliński D., Faron-Górecka A., Szafrański P., Cegła M., Filip M. Changes in the cannabinoids receptors in rats following treatment with antidepressants . Neurotoxicology, 2017, 63, 13-20
Dąbrowska M., Starek M., Komsta Ł., Szafrański P., Stasiewicz-Urban A., Opoka W. Assessment of the chromatographic lipophilicity of eight cephalosporins on different stationary phases. European Journal of Pharmaceutical Sciences, 2017, 101, 115124
2016
Tarsa M., Starek M., Zuchowski G., Stasiewicz-Urban A., Cegła M. Kinetics of Hydrolysis ofN-Methyl-2,4-dithiophenobarbital. Aust. J. Chem., 2016, 69, 89–97
2015
Szafrański P.W., Kasza P., Cegła M. A new water-soluble ligand for efficient copper-catalyzed Huisgen cycyloaddition of aliphatic azides and alkynes. Tetrahedron Letters, 2015, 56, 6244-6247
Szafrański P.W., Kasza P., Kępczyński M., Cegła T.M. Fluorescent 1,2,3-triazole derivative of 3’-deoxy-3-azidothymidine: Synthesis and absorbtion/emission spectra. Heterocycl.Commun., 2015, 21, 263-267
Waszkielewicz A., Gunia-Krzyzak A., Cegla M., Marona H. Synthesis and evaluation of anticonvulsant activity of n-(2,5-dimethylphenoxy)- and n-[(2,3,5-trimethylphenoxy)alkyl]aminoalkanols. Acta Poloniae Pharmaceutica, 2015, 72, 89-99
